LGVN Stock Analysis: Buy, Sell, or Hold?
LGVN - Longeveron Inc. Common Stock
$0.84
0.02 (2.02%)
▲
5d:
+14.19%
30d:
+39.15%
90d:
+17.17%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When LGVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: LGVN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: LGVN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: LGVN is currently trading at $0.84, which is considered extended relative to its 30-day fair value range of $0.61 to $0.77.
Technical Outlook: Technically, LGVN is in a strong downtrend. Immediate support is located at $0.67, while resistance sits at $0.89.
Market Sentiment: LGVN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.15 (+746.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LGVN is in a strong downtrend. Immediate support is located at $0.67, while resistance sits at $0.89.
Market Sentiment: LGVN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.15 (+746.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.61 -
$0.77
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range (+9.7% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 746.3% below Wall St target ($7.15)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.61 -
$0.77
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.67
Resistance Level
$0.89
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.80
Wall Street Target
$7.15
(+746.3%)
Revenue Growth (YoY)
-9.2%
Share & Embed Analysis
Last updated: August 24, 2026 8:03 AM ET
Data refreshes hourly during market hours. Next update: 9:03 AM
Data refreshes hourly during market hours. Next update: 9:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LGVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 41 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 37 SELL |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 50 HOLD |
